SUMMARY A prospective, randomized, double-blinded, placebo-controlled 
Tonsillectomy with or without adenoidectomy is one of the most commonly performed surgical procedures in children. The incidence of postoperative vomiting following this procedure is up to 70%
1 . Vomiting causes distress and anxiety for patients and parents, and may result in dehydration, metabolic disturbances, delayed discharge from hospital as well as unplanned hospital admission. Such sequelae are undesirable and costly.
Numerous studies have evaluated methods of reducing postoperative morbidity in tonsillectomy patients with varying results. In recent years there has been considerable interest in dexamethasone for reducing postoperative nausea and vomiting. Although the mechanism of its antiemetic effect is not known, dexamethasone has been used as an antiemetic drug during chemotherapy in oncology patients [2] [3] [4] . Dexamethasone has a long duration of action with a biological half-life up to 72 hours 5 . It is an inexpensive drug at a cost of $0.80 per 4mg ampoule.
Results of studies examining the efficacy of dexamethasone in reducing morbidity following tonsillectomy have been conflicting [6] [7] [8] [9] [10] [11] [12] . In view of this, we undertook to evaluate the effect of a single preoperative dose of intravenous dexamethasone on postoperative vomiting and pain in the initial 24 hours following surgery in children undergoing elective non day-case tonsillectomy with or without adenoidectomy.
MATERIALS AND METHODS
A randomized, double-blind, placebo-controlled clinical trial was conducted at the New Children's Hospital following approval by the Hospital Ethics Committee. Informed written consent was obtained from the parents of 42 ASA 1 and 2 children aged between two and 12 years scheduled for elective inpatient tonsillectomy with or without adenoidectomy. One patient was excluded from the study following postponement of surgery due to inadequate fasting. Forty-one patients were randomly allocated to receive dexamethasone 400 µg/kg (maximum dose 8 mg) or normal saline placebo at induction using biased coin randomization. Exclusion criteria included a known allergy to dexamethasone, an ASA physical status 3 or greater or a history of severe postoperative vomiting.
The anaesthetic technique was standardized according to current routine clinical practice. Guidelines for the preferred anaesthetic for children enrolled in the study were given to anaesthetists participating in the study. Patients were fasted six hours for solids and three hours for clear fluids. No premedication was given. Following an inhalational induction with sevoflurane or halothane or an intra-venous propofol induction, rocuronium 0.5 mg/kg was used to facilitate intubation. Patients were ventilated during surgery. Maintenance of anaesthesia was provided with nitrous oxide and either isoflurane or halothane. A reversal dose of neostigmine 40 µg/kg with atropine 20 µg/kg was administered at the completion of surgery. Patients were given rectal paracetamol 20 mg/kg at induction followed by intravenous pethidine (total 1 mg/kg) intraoperatively. The postoperative analgesic regimen included paracetamol 15 mg/kg orally fourth hourly as required and codeine phosphate 0.5 mg/kg orally fourth hourly as required. Patients received Hartmann's solution 20 ml/kg intraoperatively with no routine postoperative intravenous fluid therapy. All patients were charted for ondansetron 100 µg/kg as rescue antiemetic postoperatively following the second episode of vomiting.
Patients remained in hospital for approximately 24 hours prior to discharge. Attending nursing staff documented the times of first postoperative fluid and solid intakes and the time of vomiting episodes. Each patient was assessed by a single-blinded observer (F.V.) measuring postoperative pain using the Objective Pain Scale 13 immediately postoperatively in the recovery ward prior to transfer to the ward and then again at four, eight and 24 hours. The same observer reviewed postoperative oral intake at these times and ordered intravenous fluid therapy to commence if the oral intake was less than half the patient's normal fluid requirement. Administration of ondansetron by nursing staff and total analgesic requirements for the first 24 hour postoperative period were also recorded.
Data was analysed using the statistical program SPSS for Windows, Release 8.0.1. Parametric data including patient demographics of age and weight, and postoperative analgesic requirements were analysed using Student's t test. Analysis of the type of operation, induction agent used and pain scores was performed using χ 2 analysis. Fisher's exact test was used to analyse patient gender, maintenance agent used, the requirement for rescue ondansetron and commencement of postoperative intravenous fluid therapy. The Mann-Whitney test was used for analysis of postoperative vomiting and the time to first oral fluid and solid intakes. A P value <0.05 was considered statistically significant.
RESULTS
Data from 41 patients were analysed: 22 received dexamethasone and 19 received the placebo. The demographic profile and the type of surgery were similar for the two groups ( Table 1) . The induction and maintenance agents used were not statistically significantly different between the two groups.
Overall the incidence of vomiting was 45% in the dexamethasone group and 63% in the placebo group (P=0.02), although most patients in the dexamethasone group only vomited once.
The time to first oral fluid intake was similar in both the dexamethasone and placebo groups. However, the time to first solid intake was found to be significantly earlier in the dexamethasone group (Table 5 ). The requirement for both ondansetron and commencement of intravenous fluid therapy in the postoperative period was significantly lower in the dexamethasone group (Table 6 ). The placebo group was more likely to require rescue ondansetron than the study group (Odds ratio=11.1, 95% CI:1.9-44.0).
The pain scores in the two groups were not significantly different (Table 7) . Analgesic requirements for paracetamol and codeine phosphate in the two groups were similar.
DISCUSSION
The results of this study indicate that dexamethasone alters the postoperative course of children undergoing tonsillectomy, reducing the incidence of postoperative vomiting in the first 24 hours following surgery and promoting earlier postoperative eating. These results are in contrast to earlier studies, which found no significant effect of a single dose of dexamethasone in reducing the incidence of nausea and vomiting or in improving the oral intake in children undergoing tonsillectomy 6, 7 . In another double-blind, placebo-controlled study, steroid-treated patients returned to a full or semi-full diet in a shorter time compared with control patients 8 . However no significant differences were observed in postoperative pain, nausea or vomiting. Lack of standardization of anaesthetic technique in earlier studies may have contributed to these results.
Our results are consistent with the findings of other more recent studies including a double-blind, placebo-controlled clinical trial in which children undergoing tonsillectomy and adenoidectomy receiving dexamethasone had significantly less vomiting and increased oral intake at 24 hours 9 . Another placebo-controlled study showed a lower incidence of vomiting as well as a more rapid return to a normal diet in children given dexamethasone prior to tonsillectomy compared with controls 10 . Similarly, a placebo-controlled trial of a single preoperative dose of dexamethasone showed a significant reduction in the incidence of emesis after tonsillectomy 11 . A more recent double-blind, placebo-controlled study found that a single large preoperative dose of dexamethasone (1 mg/kg; maximal dose 25 mg) did not result in any difference in postoperative nausea and vomiting, need for rescue antiemetics, quality of oral intake or analgesic requirement prior to discharge in day-only paediatric tonsillectomy patients 12 . However the study found dexamethasone significantly reduces the incidence of postoperative nausea and vomiting and improved oral intake in the 24 hours after discharge.
Overall, pain scores were low and pain control was satisfactory in both groups. Although dexamethasone did not influence pain scores significantly, there did appear to be a trend towards lower scores, especially at four hours. A larger sample size might detect a significant difference in analgesic effect.
The dose of dexamethasone chosen in our study is the dose used in the management of croup at our hospital. This is a larger dose compared with previous studies 6, 8, 11 except for one 12 . Literature searches performed by ourselves and by previous investigators 6, 8, 11, 14 indicate that no adverse effect associated with the use of a single dose of dexamethasone has been reported in the literature. However, if the use of dexamethasone as an antiemetic in tonsillectomy in children is to be adopted as routine clinical practice, further studies examining the minimum effective intravenous dose of dexamethasone are required. In addition, studies examining the efficacy of dexamethasone compared with a standard antiemetic in other areas of paediatric surgery that are associated with a high incidence of postoperative vomiting such as squint surgery appear warranted.
